Newsfeeds - Spark Newswire

1 minute read

Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands

Today, 6:11 PM

Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stock with a Buy rating. Reata Pharmaceuticals shares rose 1.9% to close at $36.03 on Friday.

1 minute read

Analyst Ratings

Analyst Ratings for Petco Health and Wellness

By Benzinga Insights

Today, 6:11 PM

Petco Health and Wellness (NASDAQ:WOOF) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish…

WOOF

1 minute read

Wells Fargo Maintains Overweight on Petco Health and Wellness, Lowers Price Target to $14

By Benzinga Newsdesk

Today, 6:11 PM

Wells Fargo analyst Zachary Fadem maintains Petco Health and Wellness (NASDAQ:WOOF) with a Overweight and lowers the price target from $19 to $14.

WOOF

23 minute read

News
Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 6:11 PM

On Monday, 413 companies reached new 52-week lows.

AAN

25 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 6:11 PM

On Friday morning, 446 companies hit new 52-week lows.

ABG

2 minute read

Analyst Ratings

Expert Ratings for Petco Health and Wellness

By Benzinga Insights

Today, 6:11 PM

Over the past 3 months, 7 analysts have published their opinion on Petco Health and Wellness (NASDAQ:WOOF) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

WOOF

12 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 6:11 PM

On Wednesday, 200 companies hit new 52-week lows.

AAN

1 minute read

Evercore ISI Group Downgrades Petco Health and Wellness to In-Line, Lowers Price Target to $12

By Benzinga Newsdesk

Today, 6:11 PM

Evercore ISI Group analyst Oliver Wintermantel downgrades Petco Health and Wellness (NASDAQ:WOOF) from Outperform to In-Line and lowers the price target from $15 to $12.

WOOF